Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Bornhäuser

Showing results (1-10 of 533) with videos related to

Pageof 54
Sort By:
The Lancet. Oncology|August 4, 2015
Vosaroxin in acute myeloid leukaemiaMartin Bornhäuser
Blood|April 6, 2023
T cells reloaded after allogeneic HCTMartin Bornhäuser
Haematologica|April 9, 2026
FLT3 inhibition after transplantation: real-world evidence confirms common practiceMartin Bornhäuser
Haematologica|June 2, 2019
Conditioning intensity and antilymphocyte globulin: towards personalized transplant strategies?Martin Bornhäuser
Methods in Molecular Biology (Clifton, N.J.)|January 7, 2003
Ex vivo expansion of umbilical cord blood cells on feeder layersMartin Bornhäuser
Lancet (London, England)|February 28, 2012
SOS for veno-occlusive disease: defibrotide prophylaxisUwe Platzbecker, Martin Bornhäuser
Frontiers in Oncology|July 5, 2023
Editorial: Deciphering the bone marrow microenvironment in hematologic malignanciesManja Wobus, Martin Bornhäuser
Blood|June 13, 2024
Unrelated donor selection with PTCyJohannes Schetelig, Martin Bornhäuser
European Journal of Cancer (Oxford, England : 1990)|September 25, 2009
Allogeneic blood stem cell transplantationGerhard Ehninger, Martin Bornhäuser
Plos Computational Biology|February 1, 2024
Ten simple rules for designing graphical abstractsHelena Klara Jambor, Martin Bornhäuser
Pageof 54

Showing results (1-10 of 533) with videos related to

Sort By:
Pageof 54
The Lancet. Oncology|August 4, 2015
Vosaroxin in acute myeloid leukaemiaMartin Bornhäuser
Blood|April 6, 2023
T cells reloaded after allogeneic HCTMartin Bornhäuser
Haematologica|April 9, 2026
FLT3 inhibition after transplantation: real-world evidence confirms common practiceMartin Bornhäuser
Haematologica|June 2, 2019
Conditioning intensity and antilymphocyte globulin: towards personalized transplant strategies?Martin Bornhäuser
Methods in Molecular Biology (Clifton, N.J.)|January 7, 2003
Ex vivo expansion of umbilical cord blood cells on feeder layersMartin Bornhäuser
Lancet (London, England)|February 28, 2012
SOS for veno-occlusive disease: defibrotide prophylaxisUwe Platzbecker, Martin Bornhäuser
Frontiers in Oncology|July 5, 2023
Editorial: Deciphering the bone marrow microenvironment in hematologic malignanciesManja Wobus, Martin Bornhäuser
Blood|June 13, 2024
Unrelated donor selection with PTCyJohannes Schetelig, Martin Bornhäuser
European Journal of Cancer (Oxford, England : 1990)|September 25, 2009
Allogeneic blood stem cell transplantationGerhard Ehninger, Martin Bornhäuser
Plos Computational Biology|February 1, 2024
Ten simple rules for designing graphical abstractsHelena Klara Jambor, Martin Bornhäuser
Pageof 54